Literature DB >> 25505196

Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis.

Khaleque Newaz Khan1, Michio Kitajima2, Koichi Hiraki2, Akira Fujishita3, Masahiro Nakashima4, Hideaki Masuzaki2.   

Abstract

Adenomyosis is commonly believed to arise from the basalis endometrium. As an estromedin growth factor, hepatocyte growth factor (HGF) exhibits multiple functions in endometriosis, a disease commonly believed to arise from the functionalis endometrium. Here, we investigated the role of HGF in the occurrence of epithelial-mesenchymal transition (EMT) in adenomyosis. Full-thickness-biopsy specimens from endometrium to myometrium were collected after hysterectomy from women with and without adenomyosis. The relationship between HGF and E-cadherin (epithelial cell marker) and N-cadherin (mesenchymal cell markers) was examined at the gene and protein levels using endometrial epithelial cells (EECs) in culture and tissues by quantitative RT-PCR and immunohistochemistry. The gene and protein expressions of two transcriptional repressors of E-cadherin, SLUG and SNAIL, were examined using Ishikawa cells and in response to HGF and estrogen (E2). HGF down-regulated E-cadherin and up-regulated N-cadherin mRNA expression in EECs, and an inverse relationship in protein expression between HGF and E-cadherin was observed in basalis endometria derived from women with diffuse and focal adenomyosis. HGF induced morphological changes of EECs from a cobblestone-like appearance to spindle-shaped cells and promoted migration of EECs. Ishikawa cells exhibited up-regulation of SLUG/SNAIL gene expression in response to both HGF and E2 with an additive effect between them. HGF- and E2-promoted SLUG/SNAIL gene expression was significantly abrogated after pretreatment of cells with anti-HGF antibody or ICI 182720, an estrogen receptor antagonist. HGF may be involved in gland invagination deep into the myometrium by inducing EMT at the endo-myometrial junction in women with adenomyosis.
© 2015 by the Society for the Study of Reproduction, Inc.

Entities:  

Keywords:  EMT; HGF; adenomyosis; basalis endometrium; estrogen

Mesh:

Substances:

Year:  2014        PMID: 25505196     DOI: 10.1095/biolreprod.114.124891

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  13 in total

1.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

2.  Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial-Myometrial Interface Disruption in Mice.

Authors:  Xi Wang; Xishi Liu; Sun-Wei Guo
Journal:  Biomedicines       Date:  2022-05-24

3.  Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.

Authors:  Marissa J Harmsen; Caroline F C Wong; Velja Mijatovic; Arjan W Griffioen; Freek Groenman; Wouter J K Hehenkamp; Judith A F Huirne
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

4.  Effects of localisation of uterine adenomyosis on outcome of in vitro fertilisation/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study.

Authors:  Takuya Iwasawa; Toshifumi Takahashi; Eri Maeda; Koichi Ishiyama; Satoshi Takahashi; Ryota Suganuma; Koki Matsuo; Masahito Tachibana; Rie Fukuhara; Hiromitsu Shirasawa; Wataru Sato; Yukiyo Kumazawa; Yukihiro Terada
Journal:  Reprod Biol Endocrinol       Date:  2021-06-04       Impact factor: 5.211

5.  Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.

Authors:  Qi Zhang; Peixin Dong; Xishi Liu; Noriaki Sakuragi; Sun-Wei Guo
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

6.  A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis.

Authors:  Xuan Che; Jianzhang Wang; Jiayi He; Qin Yu; Wenting Sun; Shuyi Chen; Gen Zou; Tiantian Li; Xinyue Guo; Xinmei Zhang
Journal:  J Cell Mol Med       Date:  2019-12-08       Impact factor: 5.310

7.  Occurrence of chronic endometritis in different types of human adenomyosis.

Authors:  Khaleque N Khan; Akira Fujishita; Kanae Ogawa; Akemi Koshiba; Taisuke Mori; Kyoko Itoh; Masahiro Nakashima; Jo Kitawaki
Journal:  Reprod Med Biol       Date:  2021-10-15

Review 8.  Origin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far.

Authors:  Christina Anna Stratopoulou; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Reprod Sci       Date:  2020-10-22       Impact factor: 3.060

9.  Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model.

Authors:  Zhixing Jin; Xiaoyi Wu; Haiou Liu; Congjian Xu
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

Review 10.  Unveiling the Pathogenesis of Adenomyosis through Animal Models.

Authors:  Xi Wang; Giuseppe Benagiano; Xishi Liu; Sun-Wei Guo
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.